Full name
DERMOPHARM 2 SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.91.Z - Intermediary retail sale, non-specialized
32 - Other manufacturing of products
41 - Construction work related to the construction of residential and non-residential buildings
47 - Retail trade
52 - Warehousing, storage, and support activities for transport
55 - Accommodation
68 - Real estate activities
73 - Advertising, market research and public relations
77 - Rental and leasing
45
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,1 | 0,1 | -0,3 | -464,1 |
EBITDA | 0 | 0,1 | -0,2 | -347 |
Short time liabilities | 2,1 | 1,6 | 1,4 | -13,1 |
Equity capital | -0,1 | -0 | -0,3 | -127 101,5 |
Operating profit (EBIT) | 0 | 0,1 | -0,3 | -409,5 |
Assets | 2 | 1,6 | 1,2 | -29,2 |
Net profit (loss) | -0,1 | 0,1 | -0,3 | -501,7 |
Cash | 0 | 0,1 | 0,1 | 20 |
Net income from sale | 2,4 | 4,1 | 3,4 | -15,8 |
Liabilities and provisions for liabilities | 2,1 | 1,6 | 1,4 | -13,1 |
Working assets | 2 | 1,6 | 1,1 | -29,4 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 77,2 | -31 648,1 | 99,9 | 31 748 |
Equity capital to total assets | -3,3 | -0 | -22,8 | -22,8 |
Gross profit margin | -2,1 | 1,8 | -7,7 | -9,5 |
EBITDA Margin | 0,2 | 2,4 | -7 | -9,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 313 | 147 | 152 | 5 |
Current financial liquidity indicator | 0.9331467151641846 | 0.9638457298278809 | 0.7829713225364685 | -0,2 |
Net dept to EBITDA | 332.43829345703125 | 12.917811393737793 | -3.810098171234131 | -16,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane